Journal
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Volume 362, Issue 3, Pages 424-430Publisher
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/jpet.117.241315
Keywords
-
Categories
Funding
- Alaska Native Science and Engineering Program
- American Heart Association
- National Institutes of Health National Institute of Neurologic Disorders and Stroke [R15NS070779]
- Alaska Space Grant Program
- Alaska INBRE [P20GM103395]
Ask authors/readers for more resources
Cardiac arrest is a leading cause of death in the United States, and, currently, therapeutic hypothermia, now called targeted temperature management (TTM), is the only recent treatment modality proven to increase survival rates and reduce morbidity for this condition. Shivering and subsequent metabolic stress, however, limit application and benefit of TTM. Stimulating central nervous system A(1) adenosine receptors (A(1)AR) inhibits shivering and nonshivering thermogenesis in rats and induces a hibernation-like response in hibernating species. In this study, we investigated the pharmacodynamics of two A(1)AR agonists in development as antishivering agents. To optimize body temperature (T-b) control, we evaluated the influence of every-other-day feeding, dose, drug, and ambient temperature (T-a) on the T-b-lowering effects of N-6-cyclohexyladenosine (CHA) and the partial A(1)AR agonist capadenoson in rats. The highest dose of CHA (1.0 mg/kg, i.p.) caused all ad libitum-fed animals tested to reach our target T-b of 32 degrees C, but responses varied and some rats overcooled to a T-b as low as 21 degrees C at 17.0 degrees C T-a. Dietary restriction normalized the response to CHA. The partial agonist capadenoson (1.0 or 2.0 mg/kg, i.p.) produced a more consistent response, but the highest dose decreased T-b by only 1.6 degrees C. To prevent over-cooling after CHA, we studied continuous i.v. administration in combination with dynamic surface temperature control. Results show that after CHA administration control of surface temperature maintains desired target T-b better than dose or ambient temperature.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available